Doxorubicin‐Induced Cytotoxicity in Adipose‐Derived Stem Cells Is Associated With Altered SAPK / JNK Signaling
The FASEB Journal · 15.08.2026 · 40 (15)
DOI: 10.1096/fj.202602293r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 30.07.2026. Verfasst von Aleksandra Skubis-Sikora und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, …. Hauptthemen laut MEDLINE: Doxorubicin, Stem Cells, MAP Kinase Signaling System, Adipose Tissue. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Science Centre - NCN, Poland, Ministry of Science and Higher Education, Student Science Clubs Create Innovation, Poland, Medical University of Silesia in Katowice (SUM).
Abstract (Originalsprache)
Adipose‐derived stem cells (ADSCs) are widely used in regenerative medicine, but their functionality declines under chemotherapeutic stress. Doxorubicin (Dox) is an effective anticancer agent known to induce long‐term toxicity in healthy tissues. Increasing evidence suggests that Dox promotes cellular dysfunction, including apoptosis, promotion of oxidative stress, and premature senescence. The SAPK/JNK signaling pathway is implicated in stress responses and may contribute to Dox‐induced aging in stem cells. However, its role in ADSC senescence and functional decline remains unclear. This study evaluated the effects of Dox on ADSC viability and aging‐associated processes, with a focus on SAPK/JNK signaling. ADSCs exposed to 0.1–100 μM Dox for 24 h showed reduced mitochondrial activity and ATP levels at clinically relevant doses (5 μM), along with disrupted cell cycle progression and cytoskeletal alterations. Dox induced both apoptosis and premature senescence and increased oxidative stress. These effects were accompanied by alterations in SAPK/JNK pathway expression. Overall, Dox promoted ADSC dysfunction, highlighting potential limitations in the therapeutic use of ADSCs during chemotherapy and emphasizing the need for protective strategies. Alterations in the SAPK/JNK signaling pathway were observed in response to Dox‐induced stress, suggesting that this pathway may contribute to the cellular stress response. These findings suggest that the development of approaches to preserve ADSC function and mitigate Dox toxicity is critical for improving the safety and efficacy of regenerative medicine applications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cytophysiology, Chair of Histology and Embryology, Faculty of Medical Sciences in Katowice, Medical University of Silesia in Katowice, Katowice, Poland.
ORCID-Profile: Aleksandra Skubis-Sikora, Kinga Pogoda-Mieszczak, Bartosz Sikora, Edyta Bogunia, Aleksandra Bryzek, Piotr Czekaj
Förderung
- National Science Centre - NCN, Poland
- Ministry of Science and Higher Education, Student Science Clubs Create Innovation, Poland
- Medical University of Silesia in Katowice (SUM)
Zitieren
APA
Skubis-Sikora, A., Pogoda-Mieszczak, K., Sikora, B., Bogunia, E., Bryzek, A., & Czekaj, P. (2026). Doxorubicin‐Induced Cytotoxicity in Adipose‐Derived Stem Cells Is Associated With Altered SAPK / JNK Signaling. The FASEB Journal, 40(15). https://doi.org/10.1096/fj.202602293r
Vancouver
Skubis-Sikora A, Pogoda-Mieszczak K, Sikora B, Bogunia E, Bryzek A, Czekaj P. Doxorubicin‐Induced Cytotoxicity in Adipose‐Derived Stem Cells Is Associated With Altered SAPK / JNK Signaling. The FASEB Journal. 2026;40(15). doi:10.1096/fj.202602293r
BibTeX
@article{SkubisSikora2026,
author = {Skubis-Sikora, Aleksandra and Pogoda-Mieszczak, Kinga and Sikora, Bartosz and Bogunia, Edyta and Bryzek, Aleksandra and Czekaj, Piotr},
title = {Doxorubicin‐Induced Cytotoxicity in Adipose‐Derived Stem Cells Is Associated With Altered SAPK / JNK Signaling},
journal = {The FASEB Journal},
year = {2026},
volume = {40},
number = {15},
doi = {10.1096/fj.202602293r}
}
EUVIMED